Mette Friberg Hitz
Clinical Associate Professor
Department of Clinical Medicine
Blegdamsvej 3
2200 København N.
Member of:
Internal Medicine: Endocrinology
1 - 3 out of 3Page size: 10
- Published
Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose
Mathiesen, I. H., Hitz, Mette Friberg, Katzenstein, T. L., Oturai, P., Skov, M., Jørgensen, Niklas Rye, Jensen, Peter Østrup, Mikkelsen, C. R., Krogh-Madsen, Rikke, Pressler, T. & Faurholt-Jepsen, D., 2019, In: Journal of Cystic Fibrosis. 18, 3, p. 436-441Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Mosenzon, O., Blicher, T. M., Rosenlund, S., Eriksson, J. W., Heller, S., Hels, O. H., Pratley, R., Sathyapalan, T., Desouza, C., PIONEER 5 Investigators, Abramof, R., Alpenidze, D., Aronoff, S., Astamirova, K., Barker, B., Bedel, G., Belousova, L., Benson, M., Beshay, I., Biggs, W. & 34 others, , Jul 2019, In: The Lancet Diabetes and Endocrinology. 7, 7, p. 515-527Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Bilateral atypisk femurfraktur efter langvarig antiresorptiv behandling
Solis, A. M. B., Hitz, Mette Friberg & Jensen, Jens-Erik Beck, 2019, In: Ugeskrift for Laeger. 181, 2 p., V07180506.Research output: Contribution to journal › Letter › Research › peer-review
ID: 33973150
Most downloads
-
58
downloads
Osteoporosis is associated with deteriorating clinical status in adults with cystic fibrosis
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
16
downloads
Postoperative Chronic Hypoparathyroidism and Quality of Life After Total Thyroidectomy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
16
downloads
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published